Author
Agatha A. van der Klaauw
Also Known As
A A van der Klaauw, A A. van der Klaauw, A. A. Van Der Klaauw, A. A. van der Klaauw, A.A. van der Klaauw, A. A. Van der Klaauw, Agatha A Van der Klaauw, Agatha A van der Klaauw, Agatha A. Van Der Klaauw, Agatha A. van der Klaauw
67
Publications
3.6K
Citations
34
H-Index
52
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 8 | 8 | 307 |
2 | Public Health | 3 | 3 | 106 |
3 | Endocrinology | 2 | 2 | 27 |
4 | Health Sciences | 1 | 1 | 56 |
5 | Immunology | 1 | 1 | 37 |
Agatha A. van der Klaauw
×
49
Publications
2.9K
Citations
32
H-Index
| Year | Citations | |
|---|---|---|
2013 | 195 | |
2008 | 171 | |
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial | 2022 | 170 |
2013 | 163 | |
2007 | 159 | |
2010 | 154 | |
2019 | 141 | |
2006 | 124 | |
2023 | 94 | |
2008 | 88 |
Page 1
Page 1